IP Library › Granted Patent US 11,559,610
Granted Patent B2
US 11,559,610 · App. 16/697,222 · Granted Jan 24, 2023

Low temperature cured silicone lubricious coatings

Inventors: Duan Li Ou (Warren, NJ); Christophe Vailhe (Hillborough, NJ); Frank R. Cichocki (Easton, PA)
Assignee: Ethicon, Inc.
A61L27/54A61L2/03A61L2/07A61L2/20A61L2/26A61L17/005A61L17/145A61L31/10A61L31/14A61L31/16B05B7/1606B05B7/1686B05B12/081B05B15/00B05B17/0615B05D1/02B05D3/0493C09D5/14C09D7/20C09D7/62C09D183/04C10M107/50A61L2202/181A61L2202/182A61L2300/202A61L2300/404A61L2300/606A61L2400/10A61L2420/02A61L2420/04A61L2420/06A61M11/005C10M2229/0445C10N2030/16C10N2040/50C10N2050/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,559,610
App. No.
16/697,222
Granted
Jan 24, 2023
Kind
B2
Abstract

Novel, lubricious coatings for medical devices are disclosed. The coatings provide improved lubricity and durability and are readily applied in coating processes a low temperatures that do not deform the device. The present invention is also directed to a novel platinum catalyst for use in such coatings. The catalyst provides for rapid curing, while inhibiting cross-linking at ambient temperatures, thereby improving the production pot life of the coatings.

Claims (22)

1. A medical device coated with a lubricious silicone coating, comprising:

a medical device having a surface; and,

a lubricious silicone coating on at least a part of the surface, the coating formed from a coating composition comprising:

a cross-linkable silicone polymer having reactive functionalities;

a silica-containing composition;

a silicone cross-linking agent; and,

a catalyst, wherein said catalyst is an ambient inactive catalyst and consists essentially of platinum divinyltetramethyldisiloxane vinylcyclohexanol complex having the formula:

Pt[(CH 2 ═CH)(CH 3 ) 2 Si] 2 O.C 6 H 10 (OH)(C═CH).

2. The medical device of claim 1 , wherein the cross-linkable silicone polymer is selected from the group consisting of vinyl terminated polydialkylsiloxane, vinyl terminated polydimethylsiloxane, vinyl terminated polydiphenylsilane-dimethylsiloxane copolymer, vinyl terminated polyphenylmethylsiloxane, vinyl terminated polyfluoropropylmethyl-dimethylsiloxane copolymer and vinyl terminated polydiethylsiloxane.

3. The medical device of claim 1 , wherein the cross-linkable silicone polymer comprises vinyl terminated polydimethylsiloxane.

4. The medical device of claim 1 , wherein the silica-containing composition comprises a trimethyl silyl surface treated silica filler.

5. The medical device of claim 1 , wherein the silica-containing composition is selected from the commercially available reactive silica-containing silicone bases including HCR (high consistent rubber) bases and LSR (liquid silicone rubber) bases.

6. The medical device of claim 5 , wherein the silica-containing composition is a liquid silicone rubber base.

7. The medical device of claim 1 , wherein the silicone cross-linking agent is selected from the group consisting of polymethylhydrosiloxane, polymethylhydro-co-polydimethylsiloxane, polyethylhydrosiloxane, polymethylhydrosiloxane-co-octylmethylsiloxane, and polymethylhydrosiloxane-co-methylphenylsiloxane.

8. The medical device of claim 1 , wherein the silicone cross-linking agent comprises polymethylhydrosiloxane.

9. The medical device of claim 1 , wherein the coating composition additionally comprises about 75 wt. % to about 93 wt. % of an organic solvent, based upon the weight of the coating composition.

10. The medical device of claim 1 , wherein the coating composition comprises about 0.2 wt. % to about 6 wt. % of the silicone cross-linking agent based on total solids, wherein the coating composition additionally comprises about 75 wt. % to about 93 wt. % of an organic solvent, based upon the weight of the coating composition.

11. The medical device of claim 1 , wherein the coating composition comprises about 0.0004 wt. % to about 0.0036 wt. % of the platinum catalyst, based on total solids, wherein the coating composition additionally comprises about 75 wt. % to about 99.5 wt. % of an organic solvent, based upon the weight of the coating composition.

12. The medical device of claim 1 , wherein the coating composition additionally comprises a solvent selected from the group consisting of xylene, toluene, pentane, hexane, heptanes, octane, mixtures of higher molecular weight olefins, and combinations thereof.

13. The medical device of claim 1 , wherein the medical device comprises a biocompatible material selected from the group consisting of stainless steels, PTFE, glasses, ceramics, polymers, refractory metal alloys, memory alloys, and composites of metals and non-metals.

14. The medical device of claim 1 , wherein the medical device is selected from the group consisting of surgical needles, sutures, hypodermic needles, surgical scalpels, catheters, cutting blades, surgical probes, endoscopes, scissors, and cutting blades.

15. The medical device of claim 14 , wherein the medical device comprises a surgical suture.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2020
From: OU, DUAN LI; VAILHE, CHRISTOPHE; CICHOCKI, FRANK RICHARD, JR.
To: ETHICON, INC.
Reel/Frame 054729/0549 →
Continuity (2)
Provisional Application 62773102 · Nov 29, 2018
Related Publication 20200171198A1 · Jun 4, 2020
Cited By (3)
US 12,465,577 US 12,528,913 US 12,577,400